In contrast, CD44 and FBN1 demonstrated decreases of −34.15% and −13.4%, respectively; these proteins are involved in renal tubular and extracellular matrix pathologies [24,25], though the implications of their reduced urinary levels in CKD progression require further investigation. Here, CD44 is linked to chronic kidney disease.